<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03061305</url>
  </required_header>
  <id_info>
    <org_study_id>STR-001-001</org_study_id>
    <nct_id>NCT03061305</nct_id>
  </id_info>
  <brief_title>Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors</brief_title>
  <official_title>An Observational Trial Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Strata Oncology</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Strata Oncology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many patients are treated for advanced cancer without knowledge of underlying molecular&#xD;
      features that might indicate FDA approved therapies or potential eligibility for&#xD;
      biomarker-selected clinical trials.&#xD;
&#xD;
      The Strata Trial (STR-001-001) has been initiated by Strata Oncology to evaluate the clinical&#xD;
      benefit of systematic comprehensive genomic profiling for participants with advanced cancer&#xD;
      using real-world data and endpoints, while assessing the proportion of participants available&#xD;
      for clinical trials and approved targeted therapies in advanced and/or aggressive cancers.&#xD;
      The Strata Trial uses surplus, or leftover, tumor specimens for molecular profiling and does&#xD;
      not require additional study-specific procedures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants enrolled on the Strata Trial will submit surplus, clinical formalin-fixed&#xD;
      paraffin-embedded (FFPE) tumor specimens for molecular profiling and a test report will be&#xD;
      provided back to the investigator. For those participants identified as having molecular&#xD;
      alterations associated with a Strata-affiliated therapeutic clinical trial and/or approved&#xD;
      targeted therapy or trials, the Strata reports will provide additional relevant information.&#xD;
&#xD;
      All molecular profiling will be performed in the Strata Oncology CAP-accredited and&#xD;
      CLIA-certified laboratory (Ann Arbor, MI). The molecular profiling assays will include&#xD;
      tumor-only comprehensive genomic profiling (CGP) by next generation sequencing (NGS) of DNA&#xD;
      and RNA covering a range of actionable genomic alterations, such as mutations (e.g. those in&#xD;
      EGFR and BRAF), copy number alterations (e.g. ERBB2 amplifications), gene expression, gene&#xD;
      fusions (e.g. ALK fusions), tumor mutation burden (TMB) and microsatellite instability&#xD;
      status, and may include additional integrative DNA and RNA tests over time.&#xD;
&#xD;
      Participants may be followed for treatment changes and survival for three years from the time&#xD;
      of enrollment and/or signed informed consent.&#xD;
&#xD;
      Participants may also be eligible for the Strata Trial Sub-Study at applicable Strata Trial&#xD;
      sites. This sub-study is a sample collection study to support the development and evaluation&#xD;
      of biomarker assays for patients with solid tumors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <primary_completion_date type="Anticipated">April 2026</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Genetic Alteration Frequency</measure>
    <time_frame>3 years</time_frame>
    <description>To evaluate the proportion of subjects across solid tumors and lymphomas having genetic alterations targeted by approved or investigational therapies.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of Treatment Selection</measure>
    <time_frame>3 years</time_frame>
    <description>To evaluate the proportion of advanced cancer subjects whose targeted genetic sequencing affected treatment selection and/or clinical trial enrollment.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500000</enrollment>
  <condition>Cancer</condition>
  <condition>Adult Solid Tumor</condition>
  <condition>Lymphoma</condition>
  <condition>Multiple Myeloma</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      leftover tumor tissue, DNA, RNA&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with histologically-documented solid tumors (including lymphoma or multiple&#xD;
        myeloma), and have surplus clinical FFPE tumor tissue (e.g. biopsy, fine needle aspiration,&#xD;
        fluid cytology, surgical resection) will be eligible for the Strata trial.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects must be â‰¥ 18 years of age.&#xD;
&#xD;
          -  Subjects must have histologically documented solid tumors (including lymphoma and&#xD;
             multiple myeloma).&#xD;
&#xD;
          -  Specific criteria for individual tumor types are as follows:&#xD;
&#xD;
               1. Participants with gliomas are eligible at any stage of disease&#xD;
&#xD;
               2. Participants with pancreatic carcinoma are eligible at any stage of disease&#xD;
&#xD;
               3. Participants with rare tumors (i.e. cancer started in an unusual place in the&#xD;
                  body, it is unusual type and requires special treatment) are eligible at stages&#xD;
                  II-IV.&#xD;
&#xD;
               4. Participants with other tumor types must have recurrent, relapsed, refractory,&#xD;
                  metastatic, or advanced stages III or IV cancer.&#xD;
&#xD;
          -  Must have an adequate formalin-fixed paraffin-embedded tumor specimen for genomic&#xD;
             sequencing.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kat Kwiatkowski, MPH</last_name>
    <role>Study Director</role>
    <affiliation>Strata Oncology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kat Kwiatkowski, MPH</last_name>
    <phone>734-527-0993</phone>
    <email>kat.kwiatkowski@strataoncology.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama, Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente - Southern California</name>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <zip>91101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente - Northern California</name>
      <address>
        <city>Vallejo</city>
        <state>California</state>
        <zip>94589</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>SCL Health</name>
      <address>
        <city>Broomfield</city>
        <state>Colorado</state>
        <zip>80021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Colorado</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Christiana Care Health System</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>SwedishAmerican</name>
      <address>
        <city>Rockford</city>
        <state>Illinois</state>
        <zip>61114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baptist Health</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Christus Health</name>
      <address>
        <city>Lake Charles</city>
        <state>Louisiana</state>
        <zip>70605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic Foundation</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente - Mid-Atlantic</name>
      <address>
        <city>Rockville</city>
        <state>Maryland</state>
        <zip>20852</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology - Burnsville</name>
      <address>
        <city>Burnsville</city>
        <state>Minnesota</state>
        <zip>55337</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology - Coon Rapids</name>
      <address>
        <city>Coon Rapids</city>
        <state>Minnesota</state>
        <zip>55433</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fairview Southdale Hospital</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology - Maplewood Cancer Center</name>
      <address>
        <city>Maplewood</city>
        <state>Minnesota</state>
        <zip>55109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. John's Hospital</name>
      <address>
        <city>Maplewood</city>
        <state>Minnesota</state>
        <zip>55109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Metro-Minnesota Community Oncology Research Consortium</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Regions Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology - Minneapolis</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>North Memorial Health Care</name>
      <address>
        <city>Robbinsdale</city>
        <state>Minnesota</state>
        <zip>55422</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Park Nicollet Health Services</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology - Edina</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology - Woodbury Clinic</name>
      <address>
        <city>Woodbury</city>
        <state>Minnesota</state>
        <zip>55125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>North Mississippi Medical Center</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University of North Carolina, Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27514</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hayworth Cancer Center</name>
      <address>
        <city>High Point</city>
        <state>North Carolina</state>
        <zip>27262</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>UNC REX Healthcare</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Kettering Health Network</name>
      <address>
        <city>Kettering</city>
        <state>Ohio</state>
        <zip>45429</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Northwest</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97227</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Health Network</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prisma Health Cancer Institute</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Bon Secours St. Francis</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UTHealth - Memorial Hemann Cancer Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bon Secours Midlothian</name>
      <address>
        <city>Midlothian</city>
        <state>Virginia</state>
        <zip>23114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>MultiCare</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Gundersen Health System</name>
      <address>
        <city>La Crosse</city>
        <state>Wisconsin</state>
        <zip>54601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Aurora Research Institute</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>ProHealth Care</name>
      <address>
        <city>Waukesha</city>
        <state>Wisconsin</state>
        <zip>53188</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Strata Oncology</last_name>
      <phone>734-527-1000</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 15, 2017</study_first_submitted>
  <study_first_submitted_qc>February 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2017</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Myeloma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

